Profile: Arkios BioDevelopment International is a full service global biopharmaceutical consulting group providing contract research services (CRO) to emerging technology companies developing new drugs, biologics, medical devices, and diagnostics. We focus on assisting emerging biopharmaceutical and device companies with the early stages of regulatory strategic planning process & implementation as well as in the filing of a successful investigational new drug/investigational device exemption (IND/IDE) with the FDA. We also design and manage the clinical development of emerging technologies in the biopharmaceutical and device area through successful product out-licensing or registration. Our CRO services include clinical trial design & management, monitoring/quality assurance, full regulatory affairs consulting that include data management, biostatistics, medical writing and other tasks related to clinical product development.